Impact of point-of-care B-type natriuretic peptide (BNP) measurement on medical decision-making for older Emergency Department patients with dyspnea

Journal of Emergency Medicine

Volumn 31, Issue 2, 2006, Pages 147-150

  Kosowsky, Joshua M ^a,b   Weiner, Chana ^a   Aronson, Andrew A ^a,c   Morrissey, Jennifer H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Harvard Affiliated Emergency Medicine Residency   (United States)

Author keywords

BNP; dyspnea; heart failure; medical decision making; point of care testing

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EMERGENCY CARE; EMERGENCY PHYSICIAN; FEMALE; HEART FAILURE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AGED; DECISION MAKING; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 33748066337     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2005.10.001     Document Type: Article

References (9)

1. American Heart Association. 2004 Heart and stroke statistical update (2004), American Heart Association, Washington, DC
2. Fonarow G.C. The acute decompensated heart failure national registry (ADHERE). opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21-S30
3. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from breathing not properly (BNP) multinational study. Circulation 106 (2002) 416-422
4. Gillespie N.D., McNeill G., Pringle T., Ogston S., Struthers A.D., and Pringle S.D. Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea. BMJ 314 (1997) 936
5. Maeda K., Tsutamota T., Wada A., et al. Plasma brain natriuretic peptide as a bioschemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
6. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
7. Schwam E. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients. a critical appraisal. Acad Emerg Med 11 (2004) 686-691
8. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
9. Maisel A., Hollander J.E., Guss D., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients with shortness of breath. J Am Coll Cardiol 44 (2004) 1328-1333